Paradigm: Phoenix genetic test maker gets $15M in funding; bioscience leader joins board
The latest capital infusion comes several months after a previous $9 million raise, all of which is funding the company to develop a test to ensure cancer patients can get more personalized medical care.
Read full article »
Paradigm Diagnostics is a precision medicine company that provides genetic and molecular testing services for the treatment of cancer.
Read more